P6.24 The financial incentive to market secondary patent of ritonavir and lopinavir/ritonavir

N Vernaz; G Cohen; C Combescure; B Ledergerber; A Calmy

doi:10.1136/sextrans-2017-053264.675

Article info

PDF

Policy, Advocacy, and Community Engagement in STI/HIV Research

P6.24 The financial incentive to market secondary patent of ritonavir and lopinavir/ritonavir

Free

Authors

N Vernaz 1Geneva University Hospitals, Geneva, Switzerland PubMed articles Google scholar articles
G Cohen 1Geneva University Hospitals, Geneva, Switzerland PubMed articles Google scholar articles
C Combescure 1Geneva University Hospitals, Geneva, Switzerland PubMed articles Google scholar articles
B Ledergerber 2University of Zurich, Zurich, Switzerland PubMed articles Google scholar articles
A Calmy 1Geneva University Hospitals, Geneva, Switzerland PubMed articles Google scholar articles

Citation

Vernaz N, Cohen G, Combescure C, et al

P6.24 The financial incentive to market secondary patent of ritonavir and lopinavir/ritonavir

Sexually Transmitted Infections 2017;93:A256.

Publication history

First published July 8, 2017.

Online issue publication

September 18, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password